Barclays PLC Has $7.71 Million Stock Position in Teva ... - MarketBeat

Dec 19, 2024  · Barclays PLC lifted its stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 31.7% in the 3rd quarter, according to its most recent Form 13F filing with the SEC.The institutional investor owned 427,595 shares of the company's stock …


Install CouponFollow Chrome Extension   CouponFollow Extension

7%
OFF

Barclays PLC Has $7.71 Million Stock Position In Teva ... - MarketBeat

4 weeks from now

Dec 19, 2024  · Barclays PLC lifted its stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 31.7% in the 3rd quarter, according to its most recent Form 13F filing with the SEC.The institutional investor owned 427,595 shares of the company's stock …

marketbeat.com

$7.71
OFF

Teva Pharmaceutical Industries (TEVA) News Today - MarketBeat

4 weeks from now

5 days ago  · Barclays PLC Has $7.71 Million Stock Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA) ... State Street Corp raised its position in Teva Pharmaceutical …

marketbeat.com

$28
OFF

Teva Price Target Raised To $28 From $25 At Barclays - Nasdaq

4 weeks from now

Dec 18, 2024  · Barclays analyst Balaji Prasad raised the firm’s price target on Teva (TEVA) to $28 from $25 and keeps an Overweight rating on the shares. The firm says Duvakitug with a …

nasdaq.com

$22.00
OFF

Teva Pharmaceutical (TEVA) Gets A Buy From Barclays

4 weeks from now

Sep 24, 2024  · In a report released today, Balaji Prasad from Barclays maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a price target of $22.00.The company’s …

businessinsider.com

$25.00
OFF

Barclays Reaffirms Their Buy Rating On Teva Pharmaceutical (TEVA)

4 weeks from now

Nov 6, 2024  · In a report released today, Balaji Prasad from Barclays maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a price target of $25.00.The company’s …

businessinsider.com

$25
OFF

Teva Price Target Raised To $25 From $22 At Barclays - Nasdaq

4 weeks from now

Oct 23, 2024  · Barclays raised the firm’s price target on Teva (TEVA) to $25 from $22 and keeps an Overweight rating on the shares. The firm introduced Olanzapine into its model, noting TEV …

nasdaq.com

$17.00
OFF

Barclays Sticks To Its Buy Rating For Teva Pharmaceutical (TEVA)

4 weeks from now

Feb 5, 2024  · Barclays analyst Balaji Prasad maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report) today and set a price target of $17.00. The company’s shares …

businessinsider.com

$21.20
OFF

Teva Pharmaceutical Industries Target Of Unusually ... - ETF Daily …

4 weeks from now

Dec 19, 2024  · Shares of TEVA stock opened at $21.20 on Thursday. Teva Pharmaceutical Industries has a 52-week low of $10.13 and a 52-week high of $21.98. ... Barclays PLC …

etfdailynews.com

$25.00
OFF

Barclays Forecasts Strong Price Appreciation For Teva …

4 weeks from now

Dec 20, 2024  · Teva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) had its price objective lifted by equities research analysts at Barclays from $25.00 to $28.00 in a report …

tickerreport.com

$80
OFF

Barclays Is Boosting Teva's PT - Yahoo Finance

4 weeks from now

Apr 9, 2015  · Barclays raised its price target on Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA ) Thursday to $80 and maintained an Overweight rating. The analyst note …

yahoo.com

$25.00
OFF

MML Investors Services LLC Reduces Stock Position In Teva ...

4 weeks from now

Dec 22, 2024  · Barclays upped their price objective on shares of Teva Pharmaceutical Industries from $25.00 to $28.00 and gave the stock an “overweight” rating in a research report on …

etfdailynews.com

$25
OFF

Teva Price Target Raised To $25 From $22 At Barclays

4 weeks from now

Oct 23, 2024  · Barclays raised the firm’s price target on Teva (TEVA) to $25 from $22 and keeps an Overweight rating on the shares. The firm introduced O...

businessinsider.com

$4.37
OFF

Barclays PLC Has $4.37 Million Stock Position In Jazz ... - MarketBeat

4 weeks from now

Dec 22, 2024  · The company has a debt-to-equity ratio of 1.46, a quick ratio of 3.74 and a current ratio of 4.26. Jazz Pharmaceuticals plc has a 12 month low of $99.06 and a 12 month high of …

marketbeat.com

$771.00
OFF

Radius Recycling, Inc. (NASDAQ:RDUS) Shares Acquired By …

4 weeks from now

1 day ago  · The company had revenue of $771.00 million for the quarter, compared to analysts’ expectations of $680.80 million. ... Barclays PLC Has $1.05 Million Stock Position in Universal …

defenseworld.net

$0.37
OFF

Barclays PLC Raises Stock Position In Novavax, Inc ... - MarketBeat

4 weeks from now

Dec 18, 2024  · Novavax Price Performance. Shares of NVAX stock traded down $0.37 during trading hours on Wednesday, reaching $8.63. 3,815,405 shares of the company traded hands, …

marketbeat.com

$25.00
OFF

Teva Pharmaceutical (TEVA) Receives A Buy From Barclays

4 weeks from now

Oct 23, 2024  · Barclays analyst Balaji Prasad maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report) today and set a price target of $25.00. The company’s shares …

businessinsider.com

6%
OFF

Barclays PLC Has $23.89 Million Stock Position In Rio ... - MarketBeat

4 weeks from now

Dec 15, 2024  · Barclays PLC raised its holdings in Rio Tinto Group (NYSE:RIO - Free Report) by 225.6% during the 3rd quarter, according to the company in its most recent Form 13F filing …

marketbeat.com

11%
OFF

Radius Recycling, Inc. (NASDAQ:RDUS) Shares Acquired By …

4 weeks from now

1 day ago  · Hedge funds and other institutional investors own 78.11% of the company's stock. Radius Recycling Trading Down 1.5 %. Shares of NASDAQ RDUS opened at $15.00 on …

marketbeat.com

FAQs about Barclays PLC Has $7.71 Million Stock Position in Teva ... - MarketBeat Coupon?

Did MML Investors cut its stake in Teva Pharmaceutical Industries Limited?

MML Investors Services LLC cut its stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) by 13.5% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 36,529 shares of the company’s stock after selling 5,710 shares during the quarter. ...

Did state Street Corp increase its holdings in Teva Pharmaceutical Industries?

State Street Corp increased its holdings in Teva Pharmaceutical Industries by 10.0% during the 3rd quarter. State Street Corp now owns 19,500,683 shares of the company’s stock worth $351,402,000 after acquiring an additional 1,778,268 shares during the period. ...

Did hedge funds change their positions in Teva Pharmaceutical Industries?

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. FMR LLC boosted its stake in Teva Pharmaceutical Industries by 49.5% in the 3rd quarter. ...

Does Clal Insurance Enterprises Holdings Ltd own Teva Pharmaceutical Industries?

Clal Insurance Enterprises Holdings Ltd increased its holdings in Teva Pharmaceutical Industries by 6.8% during the 3rd quarter. Clal Insurance Enterprises Holdings Ltd now owns 34,543,812 shares of the company’s stock worth $621,337,000 after acquiring an additional 2,204,623 shares during the period. ...

Does Janus Henderson Group plc own Teva Pharmaceutical Industries?

Janus Henderson Group PLC boosted its holdings in Teva Pharmaceutical Industries by 7,945.2% during the third quarter. Janus Henderson Group PLC now owns 4,791,937 shares of the company’s stock worth $86,350,000 after buying an additional 4,732,374 shares in the last quarter. ...

What happened to Teva Pharmaceutical Industries Limited (Teva)?

Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report) was the recipient of unusually large options trading on Tuesday. Traders acquired 140,688 call options on the company. This is an increase of approximately 504% compared to the average daily volume of 23,306 call options. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension